Emergency heart attack care

NEW YORK, July 7 (Praxis Press) Prompt treatment of heart attacks is crucial to the survival of the patient. Two important treatments that require trained emergency medical personnel and need to be administered as quickly as possible are drugs to dissolve clots (thrombolytic agents) and defibrillation and other methods to control heart arrhythmias. Rapid access to emergency medical care is a problem in many communities and even when the decision is made to seek medical care, most patients in the

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, July 7 (Praxis Press) Prompt treatment of heart attacks is crucial to the survival of the patient. Two important treatments that require trained emergency medical personnel and need to be administered as quickly as possible are drugs to dissolve clots (thrombolytic agents) and defibrillation and other methods to control heart arrhythmias. Rapid access to emergency medical care is a problem in many communities and even when the decision is made to seek medical care, most patients in the US avoid ambulance service, preferring to get to the hospital themselves. A recent study evaluated the effect of a community-wide education program designed to decrease delay in access to medical care for patients with heart attacks. Use of emergency medical services by patients with chest pain increased significantly in communities that received the intervention, but there was no difference in the change in delay time from symptom onset to hospital ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform